Skip to Content

C2 (Rubraca 200 mg)

Generic Name: rucaparib

Pill with imprint C2 is Blue, Round and has been identified as Rubraca 200 mg. It is supplied by Clovis Oncology, Inc..

Rubraca is used in the treatment of ovarian cancer; prostate cancer and belongs to the drug class PARP inhibitors. Rubraca 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for C2

Rubraca 200 mg C2

Rubraca

Generic Name
rucaparib
Imprint
C2
Strength
200 mg
Color
Blue
Size
11.00 mm
Shape
Round
Availability
Prescription only
Drug Class
PARP inhibitors
CSA Schedule
Not a controlled drug
Labeler / Supplier
Clovis Oncology, Inc.
National Drug Code (NDC)
69660-0201
Inactive Ingredients
microcrystalline cellulose, sodium starch glycolate type A potato, silicon dioxide, magnesium stearate, titanium dioxide, magnesium silicate, FD&C Blue No. 1, FD&C Blue No. 2

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "C2"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.